The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease

Biochemical Journal

Volumn 419, Issue 1, 2009, Pages 29-49

  Ooms, Lisa M ^a   Horan, Kristy A ^a   Rahman, Parvin ^a   Seaton, Gillian ^a   Gurung, Rajendra ^a   Kethesparan, Dharini S ^a   Mitchell, Christina A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

5 phosphatase; Cancer; Diabetes; Inflammation; Lowe's syndrome; Phosphoinositide

Indexed keywords

5-PHOSPHATASE; CANCER; DIABETES; INFLAMMATION; LOWE'S SYNDROME; PHOSPHOINOSITIDE;

ALCOHOLS; ANTIGEN-ANTIBODY REACTIONS; CATALYSTS; CELL PROLIFERATION; ENZYMES; GLUCOSE; INSULIN; MAMMALS; PATHOLOGY; PHOSPHOLIPIDS; PHOSPHORIC ACID;

CELL MEMBRANES;

ACTIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GLUCOSE; GROWTH FACTOR; INSULIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN SH2; PROTEIN SKIP; SYNAPTOJANIN; UNCLASSIFIED DRUG; INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL;

ACTIN POLYMERIZATION; CELL FUNCTION; CELL MEMBRANE TRANSPORT; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VACUOLE; DIABETES MELLITUS; ENDOCYTOSIS; ENZYME REGULATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE TARGETING; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GLUCOSE HOMEOSTASIS; HEMATOPOIETIC CELL; HOST PATHOGEN INTERACTION; HUMAN; HYPERSENSITIVITY REACTION; HYPOGLYCEMIA; INSULIN RESISTANCE; LOWE SYNDROME; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY;

MAMMALIA; MUS;

DIABETES MELLITUS; HUMANS; NEOPLASMS; OCULOCEREBRORENAL SYNDROME; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES;

EID: 62749155738     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20081673     Document Type: Review

References (294)

1. Astle, M. V., Horan, K. A., Ooms, L. M. and Mitchell, C. A. (2007) The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors? Biochem. Soc. Symp. 74, 161-181
2. 2. Cell Biol. Int. 25, 1201-1206
3. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J. and Waterfield, M. D. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602
4. Wymann, M. P. and Pirola, L. (1998) Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436, 127-150
5. Anderson, K. E. and Jackson, S. P. (2003) Class I phosphoinositide 3-kinases. Int. J. Biochem. Cell Biol. 35, 1028-1033
6. Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. and Foukas, L. C. (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30, 194-204
7. βγ-regulated guanine-nucleotide exchange factor for Rac. Cell 108, 809-821
8. Donald, S., Hill, K., Lecureuil, C., Barnouin, R., Krugmann, S., Coadwell, W. J., Andrews, S. R., Walker, S. A., Hawkins, P. T., Stephens, L. R. and Welch, H. C. (2004) P-Rex2, a new guanine-nucleotide exchange factor for Rac. FEBS Lett. 572, 172-176
9. Frech, M., Andjelkovic, M., Ingley, E., Reddy, K. K., Falck, J. R. and Hemmings, B. A. (1997) High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity. J. Biol. Chem. 272, 8474-8481
10. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261-269
11. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
12. Manning, B. D. and Cantley, L. C. (2007) Akt/PKB signaling: navigating downstream. Cell 129, 1261-1274
13. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518
14. Marshall, A. J., Krahn, A. K., Ma, K., Duronio, V. and Hou, S. (2002) TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor. Mol. Cell. Biol. 22, 5479-5491
15. Torti, M., Bertoni, A., Sinigaglia, F., Balduini, C., Payrastre, B., Plantavid, M., Chap, H. and Mauco, G. (2000) The platelet cytoskeleton regulates the aggregation-dependent synthesis of phosphatidylinositol 3,4-bisphosphate induced by thrombin. FEBS Lett. 466, 355-358
16. Horan, K. A., Watanabe, K., Kong, A. M., Bailey, C. G., Rasko, J. E., Sasaki, T. and Mitchell, C. A. (2007) Regulation of Fcγ R-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3 mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup. Blood 110, 4480-4491
17. Ai, J., Maturu, A., Johnson, W., Wang, Y., Marsh, C. B. and Tridandapani, S. (2006) The inositol phosphatase SHIP-2 down-regulates Fcγ R-mediated phagocytosis in murine macrophages independently of SHIP-1. Blood 107, 813-820
18. Irvine, R. F. (2003) Nuclear lipid signalling. Nat. Rev. Mol. Cell Biol. 4, 349-360
19. Martelli, A. M., Follo, M. Y., Evangelisti, C., Fala, F., Fiume, R., Billi, A. M. and Cocco, L. (2005) Nuclear inositol lipid metabolism: more than just second messenger generation? J. Cell Biochem. 96, 285-292
20. York, J. D. (2006) Regulation of nuclear processes by inositol polyphosphates. Biochim. Biophys. Acta 1761, 552-559
21. Alcazar-Roman, A. R. and Wente, S. R. (2008) Inositol polyphosphates: a new frontier for regulating gene expression. Chromosoma 117, 1-13
22. Deleris, P., Bacqueville, D., Gayral, S., Carrez, L., Salles, J. P., Perret, B. and Breton-Douillon, M. (2003) SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J. Biol. Chem. 278, 38884-38891
23. Whisstock, J. C., Romero, S., Gurung, R., Nandurkar, H., Ooms, L. M., Bottomley, S. P. and Mitchell, C. A. (2000) The inositol polyphosphate 5-phosphatases and the apurinic/apyrimidinic base excision repair endonucleases share a common mechanism for catalysis. J. Biol. Chem. 275, 37055-37061
24. Tsujishita, Y., Guo, S., Stolz, L. E., York, J. D. and Hurley, J. H. (2001) Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase. Cell 105, 379-389
25. Guo, S., Stolz, L. E., Lemrow, S. M. and York, J. D. (1999) SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J. Biol. Chem. 274, 12990-12995
26. Nemoto, Y., Wenk, M. R., Watanabe, M., Daniell, L., Murakami, T., Ringstad, N., Yamada, H., Takei, K. and De Camilli, P. (2001) Identification and characterization of a synaptojanin 2 splice isoform predominantly expressed in nerve terminals. J. Biol. Chem. 276, 41133-41142
27. Whisstock, J. C., Wiradjaja, F., Waters, J. E. and Gurung, R. (2002) The structure and function of catalytic domains within inositol polyphosphate 5-phosphatases. IUBMB Life 53, 15-23
28. Rauh, M. J., Sly, L. M., Kalesnikoff, J., Hughes, M. R., Cao, L. P., Lam, V. and Krystal, G. (2004) The role of SHIP1 in macrophage programming and activation. Biochem. Soc. Trans. 32, 785-788
29. Lowe, M. (2005) Structure and function of the Lowe syndrome protein OCRL1. Traffic 6, 711-719
30. Pesesse, X., Backers, K., Moreau, C., Zhang, J., Blero, D., Paternotte, N. and Erneux, C. (2006) SHIP1/2 interaction with tyrosine phosphorylated peptides mimicking an immunoreceptor signalling motif. Adv. Enzyme Regul. 46, 142-153
31. Sasaoka, T., Wada, T. and Tsuneki, H. (2006) Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol. Ther. 112, 799-809
32. Vinciguerra, M. and Foti, M. (2006) PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling. Arch. Physiol. Biochem. 112, 89-104
33. Blero, D., Payrastre, B., Schurmans, S. and Erneux, C. (2007) Phosphoinositide phosphatases in a network of signalling reactions. Pflügers Arch. 455, 31-44
34. Harris, S. J., Parry, R. V., Westwick, J. and Ward, S. G. (2008) Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. J. Biol. Chem. 283, 2465-2469
35. Nicot, A. S. and Laporte, J. (2008) Endosomal phosphoinositides and human diseases. Traffic 9, 1240-1249
36. Zick, Y., Whittaker, J. and Roth, J. (1983) Insulin stimulated phosphorylation of its own receptor: activation of a tyrosine-specific protein kinase that is tightly associated with the receptor. J. Biol. Chem. 258, 3431-3434
37. Khan, A. H. and Pessin, J. E. (2002) Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45, 1475-1483
38. Yonezawa, K., Yokono, K., Shii, K., Ogawa, W., Ando, A., Hara, K., Baba, S., Kaburagi, Y., Yamamoto-Honda, R., Momomura, K. et al. (1992) In vitro association of phosphatidylinositol 3-kinase activity with the activated insulin receptor tyrosine kinase. J. Biol. Chem. 267, 440-446
39. Shisheva, A. (2003) Regulating Glut4 vesicle dynamics by phosphoinositide kinases and phosphoinositide phosphatases. Front. Biosci. 8, s945-s946
40. Saltiel, A. R. and Kahn, C. R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806
41. Porte, Jr, D., Baskin, D. G. and Schwartz, M. W. (2005) Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54, 1264-1276
42. Backers, K., Blero, D., Paternotte, N., Zhang, J. and Erneux, C. (2003) The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv. Enzyme Regul. 43, 15-28
43. Pesesse, X., Moreau, C., Drayer, A. L., Woscholski, R., Parker, P. and Erneux, C. (1998) The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett. 437, 301-303
44. Chi, Y., Zhou, B., Wang, W. Q., Chung, S. K., Kwon, Y. U., Ahn, Y. H., Chang, Y. T., Tsujishita, Y., Hurley, J. H. and Zhang, Z. Y. (2004) Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe synaptojanin and SHIP2. J. Biol. Chem. 279, 44987-44995
45. Taylor, V., Wong, M., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. and Stokoe, D. (2000) 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20, 6860-6871
46. Muraille, E., Pesesse, X., Kuntz, C. and Erneux, C. (1999) Distribution of the Src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J. 342, 697-705
47. Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. and Erneux, C. (1997) Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239, 697-700
48. Dyson, J. M., O'Malley, C. J., Becanovic, J., Munday, A. D., Berndt, M. C., Coghill, I. D., Nandurkar, H. H., Ooms, L. M. and Mitchell, C. A. (2001) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell Biol. 155, 1065-1079
49. Cas adapter protein and regulates cellular adhesion and spreading. Mol. Cell. Biol. 21, 1416-1428
50. Paternotte, N., Zhang, J., Vandenbroere, I., Backers, K., Blero, D., Kioka, N., Vanderwinden, J. M., Pirson, I. and Erneux, C. (2005) SHIP2 interaction with the cytoskeletal protein vinexin. FEBS J. 272, 6052-6066
51. Dyson, J. M., Munday, A. D., Kong, A. M., Huysmans, R. D., Matzaris, M., Layton, M. J., Nandurkar, H. H., Berndt, M. C. and Mitchell, C. A. (2003) SHIP-2 forms a tetrameric complex with filamin, actin, and GPIb-IX-V: localization of SHIP-2 to the activated platelet actin cytoskeleton. Blood 102, 940-948
52. Giuriato, S., Pesesse, X., Bodin, S., Sasaki, T., Viala, C., Marion, E., Penninger, J., Schurmans, S., Erneux, C. and Payrastre, B. (2003) SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem. J. 376, 199-207
53. Blero, D., De Smedt, F., Pesesse, X., Paternotte, N., Moreau, C., Payrastre, B. and Erneux, C. (2001) The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem. Biophys. Res. Commun. 282, 839-843
54. Sasaoka, T., Hori, H., Wada, T., Ishiki, M., Haruta, T., Ishihara, H. and Kobayashi, M. (2001) SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44, 1258-1267
55. Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H. and Kobayashi, M. (2001) Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21, 1633-1646
56. Tang, X., Powelka, A. M., Soriano, N. A., Czech, M. P. and Guilherme, A. (2005) PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem. 280, 22523-22529
57. Marion, E., Kaisaki, P. J., Pouillon, V., Gueydan, C., Levy, J. C., Bodson, A., Krzentowski, G., Daubresse, J. C., Mockel, J., Behrends, J. et al. (2002) The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51, 2012-2017
58. Kaisaki, P. J., Delepine, M., Woon, P. Y., Sebag-Montefiore, L., Wilder, S. P., Menzel, S., Vionnet, N., Marion, E., Riveline, J. P., Charpentier, G. et al. (2004) Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 53, 1900-1904
59. Marcano, A. C., Burke, B., Gungadoo, J., Wallace, C., Kaisaki, P. J., Woon, P. Y., Farrall, M., Clayton, D., Brown, M., Dominiczak, A. et al. (2007) Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertension. J. Med. Genet. 44, 603-605
60. Kagawa, S., Sasaoka, T., Yaguchi, S., Ishihara, H., Tsuneki, H., Murakami, S., Fukui, K., Wada, T., Kobayashi, S., Kimura, I. and Kobayashi, M. (2005) Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90, 2911-2919
61. Ishida, S., Funakoshi, A., Miyasaka, K., Shimokata, H., Ando, F. and Takiguchi, S. (2006) Association of SH-2 containing inositol 5′-phosphatase 2 gene polymorphisms and hyperglycemia. Pancreas 33, 63-67
62. Clement, S., Krause, U., Desmedt, F., Tanti, J. F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W. et al. (2001) The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92-97
63. Brunet, J.-F. and Pattyn, A. (2002) Phox2 genes: from patterning to connectivity. Curr. Opin. Genet. Dev. 12, 435-440
64. Morin, X., Cremer, H., Hirsch, M.-R., Kapur, R. P., Goridis, C. and Brunet, J.-F. (1997) Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 18, 411-423
65. Sleeman, M. W., Wortley, K. E., Lai, K. M., Gowen, L. C., Kintner, J., Kline, W. O., Garcia, K., Stitt, T. N., Yancopoulos, G. D., Wiegand, S. J. and Glass, D. J. (2005) Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11, 199-205
66. Manning, B. D. (2004) Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 167, 399-403
67. Kurlawalla-Martinez, C., Stiles, B., Wang, Y., Devaskar, S. U., Kahn, B. B. and Wu, H. (2005) Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 25, 2498-2510
68. Wijesekara, N., Konrad, D., Eweida, M., Jefferies, C., Liadis, N., Giacca, A., Crackower, M., Suzuki, A., Mak, T. W., Kahn, C. R. et al. (2005) Muscle-specific PTEN deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25, 1135-1145
69. Muntzel, M. S., Anderson, E. A., Johnson, A. K. and Mark, A. L. (1995) Mechanisms of insulin action on sympathetic nerve activity. Clin. Exp. Hypertens. 17, 39-50
70. Obici, S., Zhang, B. B., Karkanias, G. and Rossetti, L. (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376-1382
71. Niswender, K. D. and Schwartz, M. W. (2003) Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front. Neuroendocrinol. 24, 1-10
72. Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, Jr, M. G., Seeley, R. J. and Schwartz, M. W. (2003) Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52, 227-231
73. Bruning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Muller-Wieland, D. and Kahn, C. R. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125
74. Buettner, R., Ottinger, I., Gerhardt-Salbert, C., Wrede, C. E., Scholmerich, J. and Bollheimer, L. C. (2007) Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 292, E1871-E1878
75. Kagawa, S., Soeda, Y., Ishihara, H., Oya, T., Sasahara, M., Yaguchi, S., Oshita, R., Wada, T., Tsuneki, H. and Sasaoka, T. (2008) Impact of transgenic overexpression of SH2-containing inositol 5′-phosphatase 2 on glucose metabolism and insulin signaling in mice. Endocrinology 149, 642-650
76. Fukui, K., Wada, T., Kagawa, S., Nagira, K., Ikubo, M., Ishihara, H., Kobayashi, M. and Sasaoka, T. (2005) Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54, 1958-1967
77. γ mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis. Diabetes 56, 2235-2241
78. Kobayashi, K., Forte, T. M., Taniguchi, S., Ishida, B. Y., Oka, K. and Chan, L. (2000) The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metab., Clin. Exp. 49, 22-31
79. Bertelli, D. F., Ueno, M., Amaral, M. E., Toyama, M. H., Carneiro, E. M., Marangoni, S., Carvalho, C. R., Saad, M. J., Velloso, L. A. and Boschero, A. C. (2003) Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade. Am. J. Physiol. Endocrinol. Metab. 284, E679-E687
80. Ijuin, T., Mochizuki, Y., Fukami, K., Funaki, M., Asano, T. and Takenawa, T. (2000) Identification and characterization of a novel inositol polyphosphate 5-phosphatase. J. Biol. Chem. 275, 10870-10875
81. Gurung, R., Tan, A., Ooms, L. M., McGrath, M. J., Huysmans, R. D., Munday, A. D., Prescott, M., Whisstock, J. C. and Mitchell, C. A. (2003) Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization: the inositol 5-phosphatase SKIP localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation. J. Biol. Chem. 278, 11376-11385
82. Ijuin, T. and Takenawa, T. (2003) SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol. Cell. Biol. 23, 1209-1220
83. Schmid, A. C., Wise, H. M., Mitchell, C. A., Nussbaum, R. and Woscholski, R. (2004) Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett. 576, 9-13
84. Ijuin, T., Yu, Y. E., Mizutani, K., Pao, A., Tateya, S., Tamori, Y., Bradley, A. and Takenawa, T. (2008) Increased insulin action in SKIP heterozygous knockout mice. Mol. Cell. Biol. 28, 5184-5195
85. Kisseleva, M. V., Wilson, M. P. and Majerus, P. W. (2000) The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. J. Biol. Chem. 275, 20110-20116
86. Kong, A. M., Speed, C. J., O'Malley, C. J., Layton, M. J., Meehan, T., Loveland, K. L., Cheema, S., Ooms, L. M. and Mitchell, C. A. (2000) Cloning and characterization of a 72-kDa inositol-polyphosphate 5-phosphatase localized to the Golgi network. J. Biol. Chem. 275, 24052-24064
87. Asano, T., Mochizuki, Y., Matsumoto, K., Takenawa, T. and Endo, T. (1999) Pharbin, a novel inositol polyphosphate 5-phosphatase, induces dendritic appearances in fibroblasts. Biochem. Biophys. Res. Commun. 261, 188-195
88. Kong, A. M., Horan, K. A., Sriratana, A., Bailey, C. G., Collyer, L. J., Nandurkar, H. H., Shisheva, A., Layton, M. J., Rasko, J. E., Rowe, T. and Mitchell, C. A. (2006) Phosphatidylinositol 3-phosphate (PtdIns3P) is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane. Mol. Cell. Biol. 26, 6065-6081
89. Bertelli, D. F., Araujo, E. P., Cesquini, M., Stoppa, G. R., Gasparotto-Contessotto, M., Toyama, M. H., Felix, J. V., Carvalheira, J. B., Michelini, L. C., Chiavegatto, S. et al. (2006) Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits inositide trisphosphate accumulation in hypothalamus and regulates food intake and body weight. Endocrinology 147, 5385-5399
90. Gardner, R. J. and Brown, N. (1976) Lowe's syndrome: identification of carriers by lens examination. J. Med. Genet. 13, 449-454
91. Röschinger, W., Muntau, A. C., Rudolph, G., Roscher, A. A. and Kammerer, S. (2000) Carrier assessment in families with Lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination. Mol. Genet. Metab. 69, 213-222
92. Attree, O., Olivos, I. M., Okabe, I., Bailey, L. C., Nelson, D. L., Lewis, R. A., McInnes, R. R. and Nussbaum, R. L. (1992) The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358, 239-242
93. Ponting, C. P. (2006) A novel domain suggests a ciliary function for ASPM, a brain size determining gene. Bioinformatics 22, 1031-1035
94. Lichter-Konecki, U., Farber, L. W., Cronin, J. S., Suchy, S. F. and Nussbaum, R. L. (2006) The effect of missense mutations in the RhoGAP-homology domain on OCRL1 function. Mol. Genet. Metab. 89, 121-128
95. Bond, J., Scott, S., Hampshire, D. J., Springell, K., Corry, P., Abramowicz, M. J., Mochida, G. H., Hennekam, R. C., Maher, E. R., Fryns, J. P. et al. (2003) Protein-truncating mutations in ASPM cause variable reduction in brain size. Am. J. Hum. Genet. 73, 1170-1177
96. Kumar, A., Blanton, S. H., Babu, M., Markandaya, M. and Girimaji, S. C. (2004) Genetic analysis of primary microcephaly in Indian families: novel ASPM mutations. Clin. Genet. 66, 341-348
97. Hoopes, Jr, R. R., Shrimpton, A. E., Knohl, S. J., Hueber, P., Hoppe, B., Matyus, J., Simckes, A., Tasic, V., Toenshoff, B., Suchy, S. F. et al. (2005) Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76, 260-267
98. Sekine, T., Nozu, K., Iyengar, R., Fu, X. J., Matsuo, M., Tanaka, R., Iijima, K., Matsui, E., Harita, Y., Inatomi, J. and Igarashi, T. (2007) OCRL1 mutations in patients with Dent disease phenotype in Japan. Pediatr. Nephrol. 22, 975-980
99. Utsch, B., Bokenkamp, A., Benz, M. R., Besbas, N., Dotsch, J., Franke, I., Frund, S., Gok, F., Hoppe, B., Karle, S. et al. (2006) Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am. J. Kidney Dis. 48, e941-e914
100. Zhang, X., Jefferson, A. B., Auethavekiat, V. and Majerus, P. W. (1995) The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U.S.A. 92, 4853-4856
101. Zhang, X., Hartz, P. A., Philip, E., Racusen, L. C. and Majerus, P. W. (1998) Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 273, 1574-1582
102. Faucherre, A., Desbois, P., Nagano, F., Satre, V., Lunardi, J., Gacon, G. and Dorseuil, O. (2005) Lowe syndrome protein OCRL1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology. Hum. Mol. Genet. 14, 1441-1448
103. Schneider, J. F., Boltshauser, E., Neuhaus, T. J., Rauscher, C. and Martin, E. (2001) MRI and proton spectroscopy in Lowe syndrome. Neuropediatrics 32, 45-48
104. Choudhury, R., Diao, A., Zhang, F., Eisenberg, E., Saint-Pol, A., Williams, C., Konstantakopoulos, A., Lucocq, J., Johannes, L., Rabouille, C. et al. (2005) Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol. Biol. Cell 16, 3467-3479
105. Erdmann, K. S., Mao, Y., McCrea, H. J., Zoncu, R., Lee, S., Paradise, S., Modregger, J., Biemesderfer, D., Toomre, D. and De Camilli, P. (2007) A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev. Cell 13, 377-390
106. Ungewickell, A. J. and Majerus, P. W. (1999) Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc. Natl. Acad. Sci. U.S.A. 96, 13342-13344
107. Janmey, P. A. and Lindberg, U. (2004) Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell Biol. 5, 658-666
108. Suchy, S. F. and Nussbaum, R. L. (2002) The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am. J. Hum. Genet. 71, 1420-1427
109. Hyvola, N., Diao, A., McKenzie, E., Skippen, A., Cockcroft, S. and Lowe, M. (2006) Membrane targeting and activation of the Lowe syndrome protein OCRL1 by Rab GTPases. EMBO J. 25, 3750-3761
110. McCrea, H. J., Paradise, S., Tomasini, L., Addis, M., Melis, M. A., De Matteis, M. A. and De Camilli, P. (2008) All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding. Biochem. Biophys. Res. Commun. 369, 493-499
111. Lin, D. C., Quevedo, C., Brewer, N. E., Bell, A., Testa, J. R., Grimes, M. L., Miller, F. D. and Kaplan, D. R. (2006) APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol. Cell. Biol. 26, 8928-8941
112. Varsano, T., Dong, M. Q., Niesman, I., Gacula, H., Lou, X., Ma, T., Testa, J. R., Yates, 3rd, J. R. and Farquhar, M. G. (2006) GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol. Cell. Biol. 26, 8942-8952
113. Leheste, J. R., Rolinski, B., Vorum, H., Hilpert, J., Nykjaer, A., Jacobsen, C., Aucouturier, P., Moskaug, J. O., Otto, A., Christensen, E. I. and Willnow, T. E. (1999) Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 155, 1361-1370
114. Naccache, S. N., Hasson, T. and Horowitz, A. (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. Proc. Natl. Acad. Sci. U.S.A. 103, 12735-12740
115. Norden, A. G., Lapsley, M., Igarashi, T., Kelleher, C. L., Lee, P. J., Matsuyama, T., Scheinman, S. J., Shiraga, H., Sundin, D. P., Thakker, R. V. et al. (2002) Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J. Am. Soc. Nephrol. 13, 125-133
116. Janne, P. A., Suchy, S. F., Bernard, D., MacDonald, M., Crawley, J., Grinberg, A., Wynshaw-Boris, A., Westphal, H. and Nussbaum, R. L. (1998) Functional overlap between murine Inpp5b and OCRL1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J. Clin. Invest. 101, 2042-2053
117. Matzaris, M., Jackson, S. P., Laxminarayan, K. M., Speed, C. J. and Mitchell, C. A. (1994) Identification and characterization of the phosphatidylinositol-(4,5)-bisphosphate 5-phosphatase in human platelets. J. Biol. Chem. 269, 3397-3402
118. Jefferson, A. B. and Majerus, P. W. (1995) Properties of type II inositol polyphosphate 5-phosphatase. J. Biol. Chem. 270, 9370-9377
119. Mitchell, C. A., Connolly, T. M. and Majerus, P. W. (1989) Identification and isolation of a 75-kDa inositol polyphosphate-5-phosphatase from human platelets. J. Biol. Chem. 264, 8873-8877
120. Matzaris, M., O'Malley, C. J., Badger, A., Speed, C. J., Bird, P. I. and Mitchell, C. A. (1998) Distinct membrane and cytosolic forms of inositol polyphosphate 5-phosphatase II: efficient membrane localization requires two discrete domains. J. Biol. Chem. 273, 8256-8267
121. Shin, H.-W., Hayashi, M., Christoforidis, S., Lacas-Gervais, S., Hoepfner, S., Wenk, M. R., Modregger, J., Uttenweiler-Joseph, S., Wilm, M., Nystuen, A. et al. (2005) An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J. Cell Biol. 170, 607-618
122. Williams, C., Choudhury, R., McKenzie, E. and Lowe, M. (2007) Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway. J. Cell Sci. 120, 3941-3951
123. Nicole, S., Hamida, C. B., Beighton, P., Bakouri, S., Belal, S., Romero, N., Viljoen, D., Ponsot, G., Sammoud, A., Weissenbach, J. et al. (1995) Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping. Hum. Mol. Genet. 4, 1633-1636
124. Shearman, A. M., Hudson, T. J., Andresen, J. M., Wu, X., Sohn, R. L., Haluska, F., Housman, D. E. and Weiss, J. S. (1996) The gene for Schnyder's crystalline corneal dystrophy maps to human chromosome 1p34.1-p36. Hum. Mol. Genet. 5, 1667-1672
125. Cormand, B., Avela, K., Pihko, H., Santavuori, P., Talim, B., Topaloglu, H., de la Chapelle, A. and Lehesjoki, A. E. (1999) Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am. J. Hum. Genet. 64, 126-135
126. Konrad, M., Schaller, A., Seelow, D., Pandey, A. V., Waldegger, S., Lesslauer, A., Vitzthum, H., Suzuki, Y., Luk, J. M., Becker, C. et al. (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79, 949-957
127. Bisgaard, A. M., Kirchhoff, M., Nielsen, J. E., Brandt, C., Hove, H., Jepsen, B., Jensen, T., Ullmann, R. and Skovby, F. (2007) Transmitted cytogenetic abnormalities in patients with mental retardation: pathogenic or normal variants? Eur. J. Med. Genet. 50, 243-255
128. Janne, P. A., Dutra, A. S., Dracopoli, N. C., Charnas, L. R., Puck, J. M. and Nussbaum, R. L. (1994) Localization of the 75-kDa inositol polyphosphate-5-phosphatase (INPP5B) to human chromosome band 1p34. Cytogenet. Cell Genet. 66, 164-166
129. Janne, P. A., Rochelle, J. M., Martin-DeLeon, P. A., Stambolian, D., Seldin, M. F. and Nussbaum, R. L. (1995) Mapping of the 75-kDa inositol polyphosphate-5-phosphatase (Inpp5b) to distal mouse chromosome 4 and its exclusion as a candidate gene for dysgenetic lens. Genomics 28, 280-285
130. Hellsten, E., Bernard, D. J., Owens, J. W., Eckhaus, M., Suchy, S. F. and Nussbaum, R. L. (2002) Sertoli cell vacuolization and abnormal germ cell adhesion in mice deficient in an inositol polyphosphate 5-phosphatase. Biol. Reprod. 66, 1522-1530
131. Hellsten, E., Evans, J. P., Bernard, D. J., Janne, P. A. and Nussbaum, R. L. (2001) Disrupted sperm function and fertilin processing in mice deficient in the inositol polyphosphate 5-phosphatase Inpp5b. Dev. Biol. 240, 641-653
132. Zumbrunn, J., Kinoshita, K., Hyman, A. A. and Nathke, I. S. (2001) Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation. Curr. Biol. 11, 44-49
133. Mills, J., Digicaylioglu, M., Legg, A. T., Young, C. E., Young, S. S., Barr, A. M., Fletcher, L., O'Connor, T. P. and Dedhar, S. (2003) Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth. J. Neurosci. 23, 1638-1648
134. Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H. and Snider, W. D. (2004) NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC. Neuron 42, 897-912
135. Jiang, H., Guo, W., Liang, X. and Rao, Y. (2005) Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators. Cell 120, 123-135
136. Kim, Y., Seger, R., Suresh Babu, C. V., Hwang, S. Y. and Yoo, Y. S. (2004) A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol. Cells 18, 353-359
137. Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A. and Kaibuchi, K. (2005) GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149
138. Mochizuki, Y. and Takenawa, T. (1999) Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles. J. Biol. Chem. 274, 36790-36795
139. Ooms, L. M., Fedele, C. G., Astle, M. V., Ivetac, I., Cheung, V., Pearson, R. B., Layton, M. J., Forrai, A., Nandurkar, H. H. and Mitchell, C. A. (2006) The inositol polyphosphate 5-phosphatase, PIPP, is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol. Biol. Cell 17, 607-622
140. Muraille, E., Dassesse, D., Vanderwinden, J. M., Cremer, H., Rogister, B., Erneux, C. and Schiffmann, S. N. (2001) The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience 105, 1019-1030
141. Aoki, K., Nakamura, T., Inoue, T., Meyer, T. and Matsuda, M. (2007) An essential role for the SHIP2-dependent negative feedback loop in neuritogenesis of nerve growth factor-stimulated PC12 cells. J. Cell Biol. 177, 817-827
142. McPherson, P. S., Takei, K., Schmid, S. L. and De Camilli, P. (1994) p145, a major Grb2-binding protein in brain, is co-localized with dynamin in nerve terminals where it undergoes activity-dependent dephosphorylation. J. Biol. Chem. 269, 30132-30139
143. Woscholski, R., Finan, P. M., Radley, E., Totty, N. F., Sterling, A. E., Hsuan, J. J., Waterfield, M. D. and Parker, P. J. (1997) Synaptojanin is the major constitutively active phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase in rodent brain. J. Biol. Chem. 272, 9625-9628
144. McPherson, P. S., Garcia, E. P., Slepnev, V. I., David, C., Zhang, X., Grabs, D., Sossin, W. S., Bauerfeind, R., Nemoto, Y. and De Camilli, P. (1996) A presynaptic inositol-5-phosphatase. Nature 379, 353-357
145. Ramjaun, A. R. and McPherson, P. S. (1996) Tissue-specific alternative splicing generates two synaptojanin isoforms with differential membrane binding properties. J. Biol. Chem. 271, 24856-24861
146. Nemoto, Y., Arribas, M., Haffner, C. and DeCamilli, P. (1997) Synaptojanin 2, a novel synaptojanin isoform with a distinct targeting domain and expression pattern. J. Biol. Chem. 272, 30817-30821
147. Seet, L. F., Cho, S., Hessel, A. and Dumont, D. J. (1998) Molecular cloning of multiple isoforms of synaptojanin 2 and assignment of the gene to mouse chromosome 17A2-3.1. Biochem. Biophys. Res. Commun. 247, 116-122
148. McPherson, P. S., Czernik, A. J., Chilcote, T. J., Onofri, F., Benfenati, F., Greengard, P., Schlessinger, J. and De Camilli, P. (1994) Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I. Proc. Natl. Acad. Sci. U.S.A. 91, 6486-6490
149. Ahn, S. J., Han, S. J., Mo, H. J., Chung, J. K., Hong, S. H., Park, T. K. and Kim, C. G. (1998) Interaction of phospholipase Cγ 1 via its COOH-terminal Src homology 2 domain with synaptojanin. Biochem. Biophys. Res. Commun. 244, 62-67
150. Haffner, C., Di Paolo, G., Rosenthal, J. A. and de Camilli, P. (2000) Direct interaction of the 170 kDa isoform of synaptojanin 1 with clathrin and with the clathrin adaptor AP-2. Curr. Biol. 10, 471-474
151. Yeow-Fong, L., Lim, L. and Manser, E. (2005) SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1. FEBS Lett. 579, 5040-5048
152. Krendel, M., Osterweil, E. K. and Mooseker, M. S. (2007) Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in endocytosis. FEBS Lett. 581, 644-650
153. Ringstad, N., Nemoto, Y. and De Camilli, P. (1997) The SH3p4/Sh3p8/ SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc. Natl. Acad. Sci. U.S.A. 94, 8569-8574
154. Schuske, K. R., Richmond, J. E., Matthies, D. S., Davis, W. S., Runz, S., Rube, D. A., van der Bliek, A. M. and Jorgensen, E. M. (2003) Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin. Neuron 40, 749-762
155. Lee, S. Y., Wenk, M. R., Kim, Y., Nairn, A. C. and De Camilli, P. (2004) Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl. Acad. Sci. U.S.A. 101, 546-551
156. Marza, E., Long, T., Saiardi, A., Sumakovic, M., Eimer, S., Hall, D. H. and Lesa, G. M. (2008) Polyunsaturated fatty acids influence synaptojanin localization to regulate synaptic vesicle recycling. Mol. Biol. Cell 19, 833-842
157. Cremona, O. and De Camilli, P. (2001) Phosphoinositides in membrane traffic at the synapse. J. Cell Sci. 114, 1041-1052
158. Wenk, M. R. and De Camilli, P. (2004) Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. Proc. Natl. Acad. Sci. U.S.A. 101, 8262-8269
159. Bauerfeind, R., Takei, K. and De Camilli, P. (1997) Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals. J. Biol. Chem. 272, 30984-30992
160. Irie, F., Okuno, M., Pasquale, E. B. and Yamaguchi, Y. (2005) EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1. Nat. Cell Biol. 7, 501-509
161. Adayev, T., Chen-Hwang, M. C., Murakami, N., Wang, R. and Hwang, Y. W. (2006) MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins. Biochem. Biophys. Res. Commun. 351, 1060-1065
162. Cremona, O., Di Paolo, G., Wenk, M. R., Luthi, A., Kim, W. T., Takei, K., Daniell, L., Nemoto, Y., Shears, S. B., Flavell, R. A. et al. (1999) Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99, 179-188
163. Harris, T. W., Hartwieg, E., Horvitz, H. R. and Jorgensen, E. M. (2000) Mutations in synaptojanin disrupt synaptic vesicle recycling. J. Cell Biol. 150, 589-600
164. Jospin, M., Watanabe, S., Joshi, D., Young, S., Hamming, K., Thacker, C., Snutch, T. P., Jorgensen, E. M. and Schuske, K. (2007) UNC-80 and the NCA ion channels contribute to endocytosis defects in synaptojanin mutants. Curr. Biol. 17, 1595-1600
165. Verstreken, P., Koh, T. W., Schulze, K. L., Zhai, R. G., Hiesinger, P. R., Zhou, Y., Mehta, S. Q., Cao, Y., Roos, J. and Bellen, H. J. (2003) Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron 40, 733-748
166. Dickman, D. K., Lu, Z., Meinertzhagen, I. A. and Schwarz, T. L. (2006) Altered synaptic development and active zone spacing in endocytosis mutants. Curr. Biol. 16, 591-598
167. Cheon, M. S., Kim, S. H., Ovod, V., Kopitar Jerala, N., Morgan, J. I., Hatefi, Y., Ijuin, T., Takenawa, T. and Lubec, G. (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III). Amino Acids 24, 127-134
168. Arai, Y., Ijuin, T., Takenawa, T., Becker, L. E. and Takashima, S. (2002) Excessive expression of synaptojanin in brains with Down syndrome. Brain Dev. 24, 67-72
169. Voronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., Schmidt, C., Akeson, E. C., Wenk, M. R., Cimasoni, L. et al. (2008) Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc. Natl. Acad. Sci. U.S.A. 105, 9415-9420
170. Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T. and Davisson, M. T. (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 11, 177-184
171. Stasko, M. R. and Costa, A. C. (2004) Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome. Behav. Brain. Res. 154, 1-17
172. Cremona, O., Nimmakayalu, M., Haffner, C., Bray-Ward, P., Ward, D. C. and De Camilli, P. (2000) Assignment of SYNJ1 to human chromosome 21q22.2 and Synj12 to the murine homologous region on chromosome 16C3-4 by in situ hybridization. Cytogenet. Cell Genet. 88, 89-90
173. Saito, T., Guan, F., Papolos, D. F., Lau, S., Klein, M., Fann, C. S. and Lachman, H. M. (2001) Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol. Psychiatry 6, 387-395
174. Parker, J. A., Metzler, M., Georgiou, J., Mage, M., Roder, J. C., Rose, A. M., Hayden, M. R. and Neri, C. (2007) Huntingtin-interacting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity. J. Neurosci. 27, 11056-11064
175. Kato, M. and Dobyns, W. B. (2003) Lissencephaly and the molecular basis of neuronal migration. Hum. Mol. Genet. 12, R89-R96
176. Cardoso, C., Leventer, R. J., Ward, H. L., Toyo-Oka, K., Chung, J., Gross, A., Martin, C. L., Allanson, J., Pilz, D. T., Olney, A. H. et al. (2003) Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am. J. Hum. Genet. 72, 918-930
177. Srinivasan, S., Seaman, M., Nemoto, Y., Daniell, L., Suchy, S. F., Emr, S., De Camilli, P. and Nussbaum, R. (1997) Disruption of three phosphatidylinositol-polyphosphate 5-phosphatase genes from Saccharomyces cerevisiae results in pleiotropic abnormalities of vacuole morphology, cell shape, and osmohomeostasis. Eur. J. Cell Biol. 74, 350-360
178. Singer-Kruger, B., Nemoto, Y., Daniell, L., Ferro-Novick, S. and De Camilli, P. (1998) Synaptojanin family members are implicated in endocytic membrane traffic in yeast. J. Cell Sci. 111, 3347-3356
179. Ha, S. A., Torabinejad, J., DeWald, D. B., Wenk, M. R., Lucast, L., De Camilli, P., Newitt, R. A., Aebersold, R. and Nothwehr, S. F. (2003) The synaptojanin-like protein Inp53/Sjl3 functions with clathrin in a yeast TGN-to-endosome pathway distinct from the GGA protein-dependent pathway. Mol. Biol. Cell 14, 1319-1333
180. Wiradjaja, F., Ooms, L. M., Whisstock, J. C., McColl, B., Helfenbaum, L., Sambrook, J. F., Gething, M. J. and Mitchell, C. A. (2001) The yeast inositol polyphosphate 5-phosphatase Inp54p localizes to the endoplasmic reticulum via a C-terminal hydrophobic anchoring tail: regulation of secretion from the endoplasmic reticulum. J. Biol. Chem. 276, 7643-7653
181. Stolz, L. E., Huynh, C. V., Thorner, J. and York, J. D. (1998) Identification and characterization of an essential family of inositol polyphosphate 5-phosphatases (INP51, INP52 and INP53 gene products) in the yeast Saccharomyces cerevisiae. Genetics 148, 1715-1729
182. Ooms, L. M., McColl, B. K., Wiradjaja, F., Wijayaratnam, A. P., Gleeson, P., Gething, M. J., Sambrook, J. and Mitchell, C. A. (2000) The yeast inositol polyphosphate 5-phosphatases Inp52p and Inp53p translocate to actin patches following hyperosmotic stress: mechanism for regulating phosphatidylinositol 4,5-bisphosphate at plasma membrane invaginations. Mol. Cell. Biol. 20, 9376-9390
183. Stefan, C. J., Padilla, S. M., Audhya, A. and Emr, S. D. (2005) The phosphoinositide phosphatase Sjl2 is recruited to cortical actin patches in the control of vesicle formation and fission during endocytosis. Mol. Cell. Biol. 25, 2910-2923
184. Bottcher, C., Wicky, S., Schwarz, H. and Singer-Kruger, B. (2006) Sjl2p is specifically involved in early steps of endocytosis intimately linked to actin dynamics via the Ark1p/Prk1p kinases. FEBS Lett. 580, 633-641
185. 2 turnover is required for multiple stages during clathrin- and actin-dependent endocytic internalization. J. Cell Biol. 177, 355-367
186. Ha, S. A., Bunch, J. T., Hama, H., DeWald, D. B. and Nothwehr, S. F. (2001) A novel mechanism for localizing membrane proteins to yeast trans-Golgi network requires function of synaptojanin-like protein. Mol. Biol. Cell 12, 3175-3190
187. O'Malley, C. J., McColl, B. K., Kong, A. M., Ellis, S. L., Wijayaratnam, A. P., Sambrook, J. and Mitchell, C. A. (2001) Mammalian inositol polyphosphate 5-phosphatase II can compensate for the absence of all three yeast Sac1-like-domain-containing 5-phosphatases. Biochem. J. 355, 805-817
188. Kaksonen, M., Sun, Y. and Drubin, D. G. (2003) A pathway for association of receptors, adaptors, and actin during endocytic internalization. Cell 115, 475-487
189. Stefan, C. J., Audhya, A. and Emr, S. D. (2002) The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate. Mol. Biol. Cell 13, 542-557
190. Toret, C. P., Lee, L., Sekiya-Kawasaki, M. and Drubin, D. G. (2008) Multiple pathways regulate endocytic coat disassembly in Saccharomyces cerevisiae for optimal downstream trafficking. Traffic 9, 848-859
191. Wiradjaja, F., Ooms, L. M., Tahirovic, S., Kuhne, E., Devenish, R. J., Munn, A. L., Piper, R. C., Mayinger, P. and Mitchell, C. A. (2007) Inactivation of the phosphoinositide phosphatases Sac1p and Inp54p leads to accumulation of phosphatidylinositol 4,5-bisphosphate on vacuole membranes and vacuolar fusion defects. J. Biol. Chem. 282, 16295-16307
192. Luo, W. and Chang, A. (1997) Novel genes involved in endosomal traffic in yeast revealed by suppression of a targeting-defective plasma membrane ATPase mutant. J. Cell Biol. 138, 731-746
193. Bensen, E. S., Costaguta, G. and Payne, G. S. (2000) Synthetic genetic interactions with temperature-sensitive clathrin in Saccharomyces cerevisiae: roles for synaptojanin-like Inp53p and dynamin-related Vps1p in clathrin-dependent protein sorting at the trans-Golgi network. Genetics 154, 83-97
194. Wicky, S., Frischmuth, S. and Singer-Kruger, B. (2003) Bsp1p/Ypr171p is an adapter that directly links some synaptojanin family members to the cortical actin cytoskeleton in yeast. FEBS Lett. 537, 35-41
195. Wendland, B. and Emr, S. D. (1998) Pan1p, yeast eps15, functions as a multivalent adaptor that coordinates protein-protein interactions essential for endocytosis. J. Cell Biol. 141, 71-84
196. Morales-Johansson, H., Jenoe, P., Cooke, F. T. and Hall, M. N. (2004) Negative regulation of phosphatidylinositol 4,5-bisphosphate levels by the INP51-associated proteins TAX4 and IRS4. J. Biol. Chem. 279, 39604-39610
197. Haffner, C., Takei, K., Chen, H., Ringstad, N., Hudson, A., Butler, M. H., Salcini, A. E., Di Fiore, P. P. and De Camilli, P. (1997) Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Lett. 419, 175-180
198. Jiang, B.-H. and Liu, L.-Z. (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim. Biophys. Acta 1784, 150-158
199. Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y. and Mills, G. B. (2005) Exploiting the PI3K/Akt pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988-1004
200. Karakas, B., Bachman, K. E. and Park, B. H. (2006) Mutation of the PIK3CA oncogene in human cancers. Br. J. Cancer 94, 455-459
201. Carpten, J. D., Faber, A. L., Horn, C., Donoho, G. P., Briggs, S. L., Robbins, C. M., Hostetter, G., Boguslawski, S., Moses, T. Y., Savage, S. et al. (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448, 439-444
202. Li, L. and Ross, A. H. (2007) Why is PTEN an important tumor suppressor? J. Cell. Biochem. 102, 1368-1374
203. 2 levels determine PKB activity. Cell. Signalling 20, 684-694
204. Franke, T. F., Kaplan, D. R., Cantley, L. C. and Toker, A. (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665-668
205. 2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J. Biol. Chem. 277, 9027-9035
206. Yoon, J. H., Lee, J. M., Namkoong, S. E., Bae, S. M., Kim, Y. W., Han, S. J., Cho, Y. L., Nam, G. H., Kim, C. K., Seo, J. S. and Ahn, W. S. (2003) cDNA microarray analysis of gene expression profiles associated with cervical cancer. Cancer Res. Treat. 35, 451-459
207. Chow, K. U., Nowak, D., Kim, S.-Z., Schneider, B., Komor, M., Boehrer, S., Mitrou, P. S., Hoelzer, D., Weidmann, E. and Hofmann, W.-K. (2006) In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling. Pharmacol. Res. 53, 49-61
208. Quade, B. J., Wang, T. Y., Sornberger, K., Dal Cin, P., Mutter, G. L. and Morton, C. C. (2004) Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer 40, 97-108
209. Akada, M., Crnogorac-Jurcevic, T., Lattimore, S., Mahon, P., Lopes, R., Sunamura, M., Matsuno, S. and Lemoine, N. R. (2005) Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin. Cancer Res. 11, 3094-3101
210. Kim, B., Bang, S., Lee, S., Kim, S., Jung, Y., Lee, C., Choi, K., Lee, S. G., Lee, K., Lee, Y. et al. (2003) Expression profiling and subtype-specific expression of stomach cancer. Cancer Res. 63, 8248-8255
211. Ramaswamy, S., Ross, K. N., Lander, E. S. and Golub, T. R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54
212. Kisseleva, M. V., Cao, L. and Majerus, P. W. (2002) Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death. J. Biol. Chem. 277, 6266-6272
213. van't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536
214. Gruvberger, S., Ringner, M., Chen, Y., Panavally, S., Saal, L. H., Borg, A., Ferno, M., Peterson, C. and Meltzer, P. S. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979-5984
215. Prasad, N. K., Tandon, M., Badve, S., Snyder, P. W. and Nakshatri, H. (2008) Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover. Carcinogenesis 29, 25-34
216. Calle, E. E. and Kaaks, R. (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591
217. Choi, Y., Zhang, J., Murga, C., Yu, H., Koller, E., Monia, B. P., Gutkind, J. S. and Li, W. (2002) PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21, 5289-5300
218. Sumie, S., Kawaguchi, T., Komuta, M., Kuromatsu, R., Itano, S., Okuda, K., Taniguchi, E., Ando, E., Takata, A., Fukushima, N. et al. (2007) Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. Oncol. Rep. 18, 545-552
219. Zhao, X., He, M., Wan, D., Ye, Y., He, Y., Han, L., Guo, M., Huang, Y., Qin, W., Wang, M. W. et al. (2003) The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett. 190, 221-232
220. Liu, Q., Shalaby, F., Jones, J., Bouchard, D. and Dumont, D. J. (1998) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP, is expressed during hematopoiesis and spermatogenesis. Blood 91, 2753-2759
221. Geier, S. J., Algate, P. A., Carlberg, K., Flowers, D., Friedman, C., Trask, B. and Rohrschneider, L. R. (1997) The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89, 1876-1885
222. Tu, Z., Ninos, J. M., Ma, Z., Wang, J.-W., Lemos, M. P., Desponts, C., Ghansah, T., Howson, J. M. and Kerr, W. G. (2001) Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98, 2028-2038
223. Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W. and Krystal, G. (1996) The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U.S.A. 93, 1689-1693
224. Koncz, G., Toth, G. K., Bokonyi, G., Keri, G., Pecht, I., Medgyesi, D., Gergely, J. and Sarmay, G. (2001) Co-clustering of Fc? and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein. Eur. J. Biochem. 268, 3898-3906
225. Liu, Y., Jenkins, B., Shin, J. L. and Rohrschneider, L. R. (2001) Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Mol. Cell. Biol. 21, 3047-3056
226. van Dijk, T. B., van Den Akker, E., Amelsvoort, M. P., Mano, H., Lowenberg, B. and von Lindern, M. (2000) Stem cell factor induces phosphatidylinositol 3′-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 96, 3406-3413
227. Dunant, N. M., Wisniewski, D., Strife, A., Clarkson, B. and Resh, M. D. (2000) The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the Dok1 phosphoprotein in Bcr-Abl transformed cells. Cell. Signalling 12, 317-326
228. Lemay, S., Davidson, D., Latour, S. and Veillette, A. (2000) Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol. Cell. Biol. 20, 2743-2754
229. Liu, L., Damen, J. E., Ware, M. D. and Krystal, G. (1997) Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J. Biol. Chem. 272, 10998-11001
230. Sattler, M., Salgia, R., Shrikhande, G., Verma, S., Choi, J. L., Rohrschneider, L. R. and Griffin, J. D. (1997) The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 15, 2379-2384
231. Yogo, K., Mizutamari, M., Mishima, K., Takenouchi, H., Ishida-Kitagawa, N., Sasaki, T. and Takeya, T. (2006) Src homology 2 (SH2)-containing 5′-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts. Endocrinology 147, 3307-3317
232. Roget, K., Malissen, M., Malbec, O., Malissen, B. and Daeron, M. (2008) Non-T cell activation linker promotes mast cell survival by dampening the recruitment of SHIP1 by linker for activation of T cells. J. Immunol. 180, 3689-3698
233. Kavanaugh, W. M., Pot, D. A., Chin, S. M., Deuter-Reinhard, M., Jefferson, A. B., Norris, F. A., Masiarz, F. R., Cousens, L. S., Majerus, P. W. and Williams, L. T. (1996) Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr. Biol. 6, 438-445
234. Sattler, M., Verma, S., Pride, Y. B., Salgia, R., Rohrschneider, L. R. and Griffin, J. D. (2001) SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J. Biol. Chem. 276, 2451-2458
235. Tamir, I., Stolpa, J. C., Helgason, C. D., Nakamura, K., Bruhns, P., Daeron, M. and Cambier, J. C. (2000) The RasGAP-binding protein p62dok is a mediator of inhibitory Fcγ RIIB signals in B cells. Immunity 12, 347-358
236. Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10, 1084-1095
237. Liu, L., Damen, J. E., Hughes, M. R., Babic, I., Jirik, F. R. and Krystal, G. (1997) The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J. Biol. Chem. 272, 8983-8988
238. Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G. and Humphries, R. K. (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610-1620
239. Sattler, M., Verma, S., Byrne, C. H., Shrikhande, G., Winkler, T., Algate, P. A., Rohrschneider, L. R. and Griffin, J. D. (1999) BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis. Mol. Cell. Biol. 19, 7473-7480
240. Horn, S., Endl, E., Fehse, B., Weck, M. M., Mayr, G. W. and Jucker, M. (2004) Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/ GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle. Leukemia 18, 1839-1849
241. Fukuda, R., Hayashi, A., Utsunomiya, A., Nukada, Y., Fukui, R., Itoh, K., Tezuka, K., Ohashi, K., Mizuno, K., Sakamoto, M. et al. (2005) Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc. Natl. Acad. Sci. U.S.A. 102, 15213-15218
242. Garcia-Palma, L., Horn, S., Haag, F., Diessenbacher, P., Streichert, T., Mayr, G. W. and Jucker, M. (2005) Up-regulation of the T cell quiescence factor KLF2 in a leukaemic T-cell line after expression of the inositol 5′-phosphatase SHIP-1. Br. J. Haematol. 131, 628-631
243. Luo, J. M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R. et al. (2003) Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 17, 1-8
244. Luo, J. M., Liu, Z. L., Hao, H. L., Wang, F. X., Dong, Z. R. and Ohno, R. (2004) Mutation analysis of SHIP gene in acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12, 420-426
245. Zhang, S. J., Shi, J. Y., Zhu, Y. M., Shi, Z. Z., Yan, S., Gu, B. W., Bai, X. T., Shen, Z. X. and Li, J. Y. (2006) The investigation of mutation and single nucleotide polymorphism of receptor tyrosine kinases and downstream scaffold molecules in acute myeloid leukemia. Leuk. Lymphoma 47, 2610-2616
246. Jutras, I. and Desjardins, M. (2005) Phagocytosis: at the crossroads of innate and adaptive immunity. Annu. Rev. Cell Dev. Biol. 21, 511-527
247. Herre, J., Marshall, A. S. J., Caron, E., Edwards, A. D., Williams, D. L., Schweighoffer, E., Tybulewicz, V., Reis e Sousa, C., Gordon, S. and Brown, G. D. (2004) Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104, 4038-4045
248. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T. and Nagata, S. (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439
249. Park, D., Tosello-Trampont, A.-C., Elliott, M. R., Lu, M., Haney, L. B., Ma, Z., Klibanov, A. L., Mandell, J. W. and Ravichandran, K. S. (2007) BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/ Dock180/Rac module. Nature 450, 430-434
250. Scott, C. C., Dobson, W., Botelho, R. J., Coady-Osberg, N., Chavrier, P., Knecht, D. A., Heath, C., Stahl, P. and Grinstein, S. (2005) Phosphatidylinositol-4,5-bisphosphate hydrolysis directs actin remodeling during phagocytosis. J. Cell Biol. 169, 139-149
251. 2+ signalling in HL60 neutrophils. J. Cell Sci. 119, 443-451
252. Araki, N., Johnson, M. T. and Swanson, J. A. (1996) A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 135, 1249-1260
253. Cox, D., Tseng, C.-C., Bjekic, G. and Greenberg, S. (1999) A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J. Biol. Chem. 274, 1240-1247
254. Munugalavadla, V., Borneo, J., Ingram, D. A. and Kapur, R. (2005) p85α subunit of class IA PI-3 kinase is crucial for macrophage growth and migration. Blood 106, 103-109
255. Di, A., Nelson, D. J., Bindokas, V., Brown, M. E., Libunao, F. and Palfrey, H. C. (2003) Dynamin regulates focal exocytosis in phagocytosing macrophages. Mol. Biol. Cell 14, 2016-2028
256. Niedergang, F., Colucci-Guyon, E., Dubois, T., Raposo, G. and Chavrier, P. (2003) ADP ribosylation factor 6 is activated and controls membrane delivery during phagocytosis in macrophages. J. Cell Biol. 161, 1143-1150
257. Cox, D., Berg, J. S., Cammer, M., Chinegwundoh, J. O., Dale, B. M., Cheney, R. E. and Greenberg, S. (2002) Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat. Cell Biol. 4, 469-477
258. Sendide, K., Reiner, N. E., Lee, J. S. I., Bourgoin, S., Talal, A. and Hmama, Z. (2005) Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J. Immunol. 174, 4210-4219
259. 2; CD11b/CD18). J. Exp. Med. 193, 61-71
260. Loovers, H. M., Kortholt, A., de Groote, H., Whitty, L., Nussbaum, R. L. and van Haastert, P. J. (2007) Regulation of phagocytosis in Dictyostelium by the inositol 5-phosphatase OCRL homolog Dd5P4. Traffic 8, 618-628
261. Cao, X., Wei, G., Fang, H., Guo, J., Weinstein, M., Marsh, C. B., Ostrowski, M. C. and Tridandapani, S. (2004) The inositol 3-phosphatase PTEN negatively regulates Fcα receptor signaling, but supports Toll-Like receptor 4 signaling in murine peritoneal macrophages. J. Immunol. 172, 4851-4857
262. Dormann, D., Weijer, G., Dowler, S. and Weijer, C. J. (2004) In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis. J. Cell Sci. 117, 6497-6509
263. Kamen, L. A., Levinsohn, J. and Swanson, J. A. (2007) Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes. Mol. Biol. Cell 18, 2463-2472
264. Kamen, L. A., Levinsohn, J., Cadwallader, A., Tridandapani, S. and Swanson, J. A. (2008) SHIP-1 increases early oxidative burst and regulates phagosome maturation in macrophages. J. Immunol. 180, 7497-7505
265. Pengal, R. A., Ganesan, L. P., Fang, H., Marsh, C. B., Anderson, C. L. and Tridandapani, S. (2003) SHIP-2 inositol phosphatase is inducibly expressed in human monocytes and serves to regulate Fcγ receptor-mediated signaling. J. Biol. Chem. 278, 22657-22663
266. Fox, R., Nhan, T. Q., Law, G. L., Morris, D. R., Liles, W. C. and Schwartz, S. M. (2007) PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages. EMBO J. 26, 505-515
267. Ganesan, L. P., Wei, G., Pengal, R. A., Moldovan, L., Moldovan, N., Ostrowski, M. C. and Tridandapani, S. (2004) The serine/threonine kinase Akt Promotes Fcγ receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase. J. Biol. Chem. 279, 54416-54425
268. Ren, X. D., Bokoch, G. M., Traynor-Kaplan, A., Jenkins, G. H., Anderson, R. A. and Schwartz, M. A. (1996) Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. Mol. Biol. Cell 7, 435-442
269. Tolias, K. F., Rameh, L. E., Ishihara, H., Shibasaki, Y., Chen, J., Prestwich, G. D., Cantley, L. C. and Carpenter, C. L. (1998) Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. J. Biol. Chem. 273, 18040-18046
270. Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P. and Kalogeromitros, D. (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217, 65-78
271. 2+ mobilization in antigen-stimulated mast cells. J. Leukocyte Biol. 65, 321-329
272. Medina-Tato, D. A., Ward, S. G. and Watson, M. L. (2007) Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunol. 121, 448-461
273. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17, 1961-1972
274. Daeron, M., Malbec, O., Latour, S., Arock, M. and Fridman, W. H. (1995) Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95, 577-585
275. Huber, M., Helgason, C. D., Damen, J. E., Liu, L., Humphries, R. K. and Krystal, G. (1998) The Src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. U.S.A. 95, 11330-11335
276. Lesourne, R., Fridman, W. H. and Daeron, M. (2005) Dynamic interactions of Fcγ receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fcγ receptor I signaling. J. Immunol. 174, 1365-1373
277. Gimborn, K., Lessmann, E., Kuppig, S., Krystal, G. and Huber, M. (2005) SHIP down-regulates FcεR1-induced degranulation at supraoptimal IgE or antigen levels. J. Immunol. 174, 507-516
278. Oh, S. Y., Zheng, T., Bailey, M. L., Barber, D. L., Schroeder, J. T., Kim, Y. K. and Zhu, Z. (2007) Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung. J. Allergy Clin. Immunol. 119, 123-131
279. athling, A., Zillikens, D., Huber, M. and Haas, H. (2006) Initial FcεRI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J. Allergy Clin. Immunol. 118, 1060-1067
280. Vonakis, B. M., Gibbons, S., Sora, R., Langdon, J. M. and MacDonald, S. M. (2001) Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J. Allergy Clin. Immunol. 108, 822-831
281. Vonakis, B. M., MacGlashan, Jr, D. W., Vilarino, N., Langdon, J. M., Scott, R. S. and MacDonald, S. M. (2008) Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils. Blood 111, 1789-1796
282. Vonakis, B. M., Vasagar, K., Gibbons, J. S. P., Gober, L., Sterba, P.
283. Leung, W.-H. and Bolland, S. (2007) The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J. Immunol. 179, 95-102
284. Kwan, M., Powell, D. R., Nachman, T. Y. and Brown, M. A. (2005) An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells. Eur. J. Immunol. 35, 1267-1274
285. Masuda, A., Yoshikai, Y., Kume, H. and Matsuguchi, T. (2004) The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol. 173, 5564-5573
286. West, M. A. and Heagy, W. (2002) Endotoxin tolerance: a review. Crit. Care Med. 30, S64-S73
287. An, H., Xu, H., Zhang, M., Zhou, J., Feng, T., Qian, C., Qi, R. and Cao, X. (2005) Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. Blood 105, 4685-4692
288. Ganesan, L. P., Joshi, T., Fang, H., Kutala, V. K., Roda, J., Trotta, R., Lehman, A., Kuppusamy, P., Byrd, J. C., Carson, W. E. et al. (2006) Fcγ R-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood 108, 718-725
289. Parsa, K. V., Ganesan, L. P., Rajaram, M. V., Gavrilin, M. A., Balagopal, A., Mohapatra, N. P., Wewers, M. D., Schlesinger, L. S., Gunn, J. S. and Tridandapani, S. (2006) Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog. 2, e71
290. Rajaram, M. V., Ganesan, L. P., Parsa, K. V., Butchar, J. P., Gunn, J. S. and Tridandapani, S. (2006) Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice. J. Immunol. 177, 6317-6324
291. Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H. and Krystal, G. (2004) LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21, 227-239
292. Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L., Minchinton, A. I., Mui, A. and Krystal, G. (2005) SHIP represses the generation of alternatively activated macrophages. Immunity 23, 361-374
293. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461
294. Bishop, J. L., Sly, L. M., Krystal, G. and Finlay, B. B. (2008) The inositol phosphatase SHIP controls Salmonella Typhimurium infection in vivo. Infect. Immun. 76, 2913-2922